Francis Chou Bausch Health Companies Inc. Transaction History

Chou Associates Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $353,000 - $1.18 Million	-50,000 Reduced 6.54%	715,000 $5.98 Million
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $16.8 Million - $21.2 Million	-730,000 Reduced 48.83%	765,000 $21.1 Million
Q1 2021 May 21, 2021	SELL	$21.37 - $34.38 $1.37 Million - $2.2 Million	-63,992 Reduced 4.1%	1,495,000 $47.4 Million
Q1 2021 May 14, 2021	BUY	$21.37 - $34.38 $427,400 - $687,600	20,000 Added 1.3%	1,558,992 $24.2 Million
Q2 2020 Aug 19, 2020	SELL	$13.31 - $20.51 $266,200 - $410,200	-20,000 Reduced 1.28%	1,538,992 $27.2 Million
Q1 2020 May 22, 2020	SELL	$12.98 - $30.25 $778,800 - $1.82 Million	-60,000 Reduced 3.71%	1,558,992 $24.2 Million
Q4 2019 Mar 04, 2020	SELL	$18.89 - $31.89 $566,700 - $956,700	-30,000 Reduced 1.82%	1,618,992 $48.4 Million
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $34 Million - $42.3 Million	1,648,992 New	1,648,992 $42.3 Million

267

252M

5.12M

9.42M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.3B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Chou Associates Management Inc., based on Form 13F filings with the SEC.

Stay updated on Chou Associates Management Inc. and Francis Chou with notifications on news.